ERYTECH Pharma S.A. ERYP
Trading inactive
| Déclarant | Citoyenneté ou lieu d'organisation | Pouvoir de vote unique | Pouvoir de vote partagé | Pouvoir de disposition unique | Pouvoir de disposition partagé | Montant en propriété effective | Pourcentage détenu | Date d'achat |
|---|---|---|---|---|---|---|---|---|
| Steven Boyd | 0 | 2737252 | 0 | 2737252 | 2737252 | 9.3 % | 14/02/2022 | |
| Armistice Capital, LLC | 0 | 2737252 | 0 | 2737252 | 2737252 | 9.3 % | 14/02/2022 | |
| Biotechnology Value Fund II, L.P. | 0 | 0 | 0 | 1979682 | 1979682 | 6.4 % | 14/02/2022 | |
| BVF I GP LLC | 0 | 0 | 0 | 2714807 | 2714807 | 8.8 % | 14/02/2022 | |
| Biotechnology Value Fund, L.P. | 0 | 0 | 0 | 2714807 | 2714807 | 8.8 % | 14/02/2022 | |
| Biotechnology Value Trading Fund OS LP | 0 | 0 | 0 | 312664 | 312664 | 1 % | 14/02/2022 | |
| BVF Partners OS Ltd. | 0 | 0 | 0 | 312664 | 312664 | 1 % | 14/02/2022 | |
| BVF GP Holdings LLC | 0 | 0 | 0 | 4694489 | 4694489 | 15.1 % | 14/02/2022 | |
| BVF Partners L.P. | 0 | 0 | 0 | 5119183 | 5119183 | 16.5 % | 14/02/2022 | |
| Mark N. Lampert | 0 | 0 | 0 | 5119183 | 5119183 | 16.5 % | 14/02/2022 | |
| BVF Inc. | 0 | 0 | 0 | 5119183 | 5119183 | 16.5 % | 14/02/2022 | |
| BVF II GP LLC | 0 | 0 | 0 | 1979682 | 1979682 | 6.4 % | 14/02/2022 | |
| BVF II GP LLC | Delaware | 0 | 0 | 0 | 1579621 | 1579621 | 7.5 % | 09/03/2021 |
| BVF Partners OS Ltd. | Delaware | 0 | 0 | 0 | 260060 | 260060 | 1.2 % | 09/03/2021 |
| Mark N. Lampert | Delaware | 0 | 0 | 0 | 4081941 | 4081941 | 19.3 % | 09/03/2021 |
| BVF Partners L.P. | Delaware | 0 | 0 | 0 | 4081941 | 4081941 | 19.3 % | 09/03/2021 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 0 | 0 | 2144331 | 2144331 | 10.1 % | 09/03/2021 |
| BVF GP HOLDINGS LLC | Delaware | 0 | 0 | 0 | 3723952 | 3723952 | 17.6 % | 09/03/2021 |
| BVF Inc. | Delaware | 0 | 0 | 0 | 4081941 | 4081941 | 19.3 % | 09/03/2021 |
| BVF I GP LLC | Delaware | 0 | 0 | 0 | 2144331 | 2144331 | 10.1 % | 09/03/2021 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 0 | 0 | 1579621 | 1579621 | 7.5 % | 09/03/2021 |
| Biotechnology Value Trading Fund OS LP | Delaware | 0 | 0 | 0 | 260060 | 260060 | 1.2 % | 09/03/2021 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 0 | 0 | 289906 | 289906 | 1.6 % | 02/01/2018 |
| BVF Partners L.P. | Delaware | 0 | 0 | 0 | 930175 | 930175 | 5.2 % | 02/01/2018 |
| BVF Inc. | Delaware | 0 | 0 | 0 | 930175 | 930175 | 5.2 % | 02/01/2018 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 0 | 0 | 436257 | 436257 | 2.4 % | 02/01/2018 |
| Biotechnology Value Trading Fund OS LP | Delaware | 0 | 0 | 0 | 74806 | 74806 | 1 % | 02/01/2018 |
| BVF Partners OS Ltd. | Delaware | 0 | 0 | 0 | 74806 | 74806 | 1 % | 02/01/2018 |
| Mark N. Lampert | Delaware | 0 | 0 | 0 | 930175 | 930175 | 5.2 % | 02/01/2018 |
| Felix J. Baker | United States | 4898337 | 0 | 4898337 | 0 | 4898337 | 27.3 % | 16/11/2017 |
| Julian C. Baker | United States | 4898337 | 0 | 4898337 | 0 | 4898337 | 27.3 % | 16/11/2017 |
| Baker Bros. Advisors LP | Delaware | 4898337 | 0 | 4898337 | 0 | 4898337 | 27.3 % | 16/11/2017 |
| Baker Bros. Advisors (GP) LLC | Delaware | 4898337 | 0 | 4898337 | 0 | 4898337 | 27.3 % | 16/11/2017 |